Cargando…

Oxaliplatin-induced peripheral neurotoxicity in colorectal cancer patients: mechanisms, pharmacokinetics and strategies

Oxaliplatin-based chemotherapy is a standard treatment approach for colorectal cancer (CRC). However, oxaliplatin-induced peripheral neurotoxicity (OIPN) is a severe dose-limiting clinical problem that might lead to treatment interruption. This neuropathy may be reversible after treatment discontinu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Fang, Zhang, Ruoqi, Sun, Chen, Ran, Qian, Zhang, Cuihan, Shen, Changhong, Yao, Ziqing, Wang, Miao, Song, Lin, Peng, Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427877/ https://www.ncbi.nlm.nih.gov/pubmed/37593174 http://dx.doi.org/10.3389/fphar.2023.1231401

Ejemplares similares

Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)
por: Argyriou, Andreas A.
Publicado: (2015)

Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity
por: Velasco, Roser, et al.
Publicado: (2021)

Efficacy of Goshajinkigan for Peripheral Neurotoxicity of Oxaliplatin in Patients with Advanced or Recurrent Colorectal Cancer
por: Kono, Toru, et al.
Publicado: (2011)

Oxaliplatin-Induced Chronic Peripheral Neurotoxicity: A Prospective Analysis in Patients with Colorectal Cancer
por: Baek, Kyung Kee, et al.
Publicado: (2010)

Chemotherapy-induced peripheral neurotoxicity and complementary and alternative medicines: progress and perspective
por: Cheng, Xiao L., et al.
Publicado: (2015)

Herbal Medicine AC591 Prevents Oxaliplatin-Induced Peripheral Neuropathy in Animal Model and Cancer Patients
por: Cheng, Xiaolan, et al.
Publicado: (2017)

Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy
por: Kerckhove, Nicolas, et al.
Publicado: (2021)

Efficacy of Exercise Rehabilitation Program in Relieving Oxaliplatin Induced Peripheral Neurotoxicity
por: Gui, Qi, et al.
Publicado: (2021)

Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-induced Peripheral Neurotoxicity
por: Nepal, Mahesh R., et al.
Publicado: (2022)

Mechanisms of manganese-induced neurotoxicity and the pursuit of neurotherapeutic strategies
por: Pajarillo, Edward, et al.
Publicado: (2022)

Stereoselective peripheral sensory neurotoxicity of diaminocyclohexane platinum enantiomers related to ormaplatin and oxaliplatin.
por: Screnci, D., et al.
Publicado: (1997)

Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights
por: Marmiroli, Paola, et al.
Publicado: (2017)

Phase I drug-interaction study of effects of calcium and magnesium infusions on oxaliplatin pharmacokinetics and acute neurotoxicity in colorectal cancer patients
por: Han, Catherine H, et al.
Publicado: (2013)

Identification of potential extracellular signal-regulated protein kinase 2 inhibitors based on multiple virtual screening strategies
por: Yang, Ruoqi, et al.
Publicado: (2022)

Supercritical fluid extract of Angelica sinensis promotes the anti-colorectal cancer effect of oxaliplatin
por: Hao, Doudou, et al.
Publicado: (2022)

Application Potential of Plant-Derived Medicines in Prevention and Treatment of Platinum-Induced Peripheral Neurotoxicity
por: Xu, Xiaowei, et al.
Publicado: (2022)

Isoliquiritigenin Alleviates Semen Strychni-Induced Neurotoxicity by Restoring the Metabolic Pathway of Neurotransmitters in Rats
por: Wang, Lu, et al.
Publicado: (2021)

Chemotherapy-induced peripheral neuropathy—part 2: focus on the prevention of oxaliplatin-induced neurotoxicity
por: Sałat, Kinga
Publicado: (2020)

Efficacy of Traditional Chinese Medicine Injection in Preventing Oxaliplatin-Induced Peripheral Neurotoxicity: An Analysis of Evidence from 3598 Patients
por: Chen, Zhi-Ying, et al.
Publicado: (2022)

Translational Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Oxaliplatin and Irinotecan in Colorectal Cancer
por: Zhu, Jinwei, et al.
Publicado: (2023)

Effects of Molecular Hydrogen on Methamphetamine-Induced Neurotoxicity and Spatial Memory Impairment
por: Wen, Di, et al.
Publicado: (2019)

Delayed Oxaliplatin-Related Severe Neurotoxicity in Metastatic Colorectal Cancer: A Case Report
por: Iimura, Yohei, et al.
Publicado: (2023)

Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancer
por: Wang, De‐shen, et al.
Publicado: (2019)

The Incidence of Oxaliplatin-Induced Peripheral Neurotoxicity at Khartoum Oncology Hospital: A Cross-Sectional Survey
por: Ali, Nadeen T., et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Capecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers
por: Chen, Ruijia, et al.
Publicado: (2022)

Sinapis Semen: A review on phytochemistry, pharmacology, toxicity, analytical methods and pharmacokinetics
por: Dang, Rui, et al.
Publicado: (2023)

Comparative efficacy and safety of Chinese medicine injections combined with capecitabine and oxaliplatin chemotherapies in treatment of colorectal cancer: A bayesian network meta-analysis
por: Liu, Shuzhen, et al.
Publicado: (2022)

Instability Mechanism of Osimertinib in Plasma and a Solving Strategy in the Pharmacokinetics Study
por: Yuan, Zheng, et al.
Publicado: (2022)

MicroRNAs in Methamphetamine-Induced Neurotoxicity and Addiction
por: Deng, Bi, et al.
Publicado: (2022)

Protective effect of compatible herbs in Jin-Gu-Lian formula against Alangium chinense-induced neurotoxicity via oxidative stress, neurotransmitter metabolisms, and pharmacokinetics
por: Lian, Dongyin, et al.
Publicado: (2023)

Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer
por: Leonard, Gregory D, et al.
Publicado: (2005)

Monosialotetrahexosylganglioside in the treatment of chronic oxaliplatin-induced peripheral neurotoxicity: TJMUCH-GI-001, a randomised controlled trial
por: Zhou, Likun, et al.
Publicado: (2021)

Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors
por: Zhu, Yanyun, et al.
Publicado: (2013)

Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage?
por: Ballarini, Elisa, et al.
Publicado: (2022)

Mechanisms of Chemotherapy-Induced Neurotoxicity
por: Was, Halina, et al.
Publicado: (2022)

Exploring the mechanisms of neurotoxicity caused by fuzi using network pharmacology and molecular docking
por: An, Junsha, et al.
Publicado: (2022)

Effect of molecular distillation on the anti-inflammatory activity and neurotoxicity of Asarum essential oil
por: Liu, Yang, et al.
Publicado: (2023)

Prevention of oxaliplatin-related neurotoxicity by ω-3 PUFAs: A double-blind randomized study of patients receiving oxaliplatin combined with capecitabine for colon cancer
por: Zhang, Xinjie, et al.
Publicado: (2020)

Development of a Physiologically Based Pharmacokinetic Model for Hydroxychloroquine and Its Application in Dose Optimization in Specific COVID-19 Patients
por: Zhang, Miao, et al.
Publicado: (2021)

Thymopentin-Mediated Inhibition of Cancer Stem Cell Stemness Enhances the Cytotoxic Effect of Oxaliplatin on Colon Cancer Cells
por: Yu, Peng-Cheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bigkjnl20b22i8eld7d413dcbt